• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

Introduction to 1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine (CAS No. 1247686-86-7)

1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 1247686-86-7, has garnered attention due to its potential applications in drug development and medicinal chemistry. The molecular structure of this pyrazole derivative incorporates a bulky tertiary butyl group, which influences its chemical reactivity and pharmacological behavior.

The< strong>1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine molecule consists of a pyrazole core substituted with a 3,3-dimethylbutyl group at the 1-position and an amine functional group at the 3-position. This arrangement contributes to its distinct physicochemical properties, including solubility, stability, and interaction with biological targets. The presence of the tertiary butyl groups enhances the compound's lipophilicity, making it a promising candidate for oral administration and membrane interactions.

In recent years, there has been growing interest in pyrazole derivatives due to their diverse biological activities. Pyrazoles are heterocyclic compounds that exhibit a wide range of pharmacological effects, including anti-inflammatory, antimicrobial, and anticancer properties. The< strong>1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine structure combines these beneficial characteristics with improved metabolic stability and reduced toxicity, making it an attractive scaffold for further medicinal chemistry exploration.

Recent studies have highlighted the potential of< strong>1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine in the development of novel therapeutic agents. For instance, research has demonstrated its efficacy in inhibiting specific enzymes involved in inflammatory pathways. The bulky substituents at the 1-position of the pyrazole ring enhance binding affinity to target proteins, leading to more potent and selective drug interactions. This has opened up new avenues for treating chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The< strong>CAS No. 1247686-86-7 identifier ensures precise identification and classification of this compound in scientific literature and regulatory databases. This standardized nomenclature facilitates accurate documentation and communication among researchers, ensuring consistency in experimental design and data interpretation. The compound's unique structural features also make it a valuable tool for computational modeling and virtual screening, which are increasingly used in drug discovery processes.

Beyond its pharmaceutical applications, 1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine has shown promise in materials science and industrial chemistry. Its stability under various conditions makes it suitable for use as an intermediate in synthesizing more complex molecules. Additionally, the compound's ability to form stable complexes with metal ions suggests potential applications in catalysis and material engineering.

The synthesis of< strong>1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Advanced synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions and asymmetric hydrogenation, have been employed to enhance reaction efficiency and selectivity. These techniques not only improve the scalability of production but also allow for the introduction of additional functional groups to tailor the compound's properties for specific applications.

In conclusion,< strong>1-(3,3-Dimethylbutyl)-1H-pyrazol-3-amine (CAS No. 1247686-86-7) is a versatile compound with significant potential in pharmaceuticals and materials science. Its unique structure and functional attributes make it a valuable building block for drug development and industrial applications. As research continues to uncover new biological activities and synthetic pathways, this compound is poised to play an increasingly important role in advancing scientific innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)